In the second study, Gu et al.52 utilised the same promoter as used here (Pax8) to drive constitutive expression of Cre recombinase from early kidney development, with mice developing renal cancers of similar histological appearances to the ones observed in our model. This evidence concerns the gene PAX8 and renal carcinoma.